Session: Updates on Targeted Therapies

Speaker: Judy Garber, MD

This 85-minute concurrent session will provide information about the current state and the history of personalized medicine and targeted drugs to prevent and treat hereditary cancers as well as future areas of research. Dr. Garber will discuss:

This session is appropriate for: